Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.

Yves Reznik,Martin Carvalho,Salha Fendri,Gaetan Prevost,Lucy Chaillous,Jean Pierre Riveline,Hélène Hanaire,Séverine Dubois,Patrick Houéto,Hélène Pasche,Beata Mianowska,Eric Renard

Diabetes, obesity & metabolism（2023）

引用 0|浏览6

暂无评分

摘要

AID combined with tailored HHC services significantly improved glycaemic control with no safety issues in people with type 2 diabetes previously under an MDI regimen with HHC. AID should be considered a safe option in these people when lacking acceptable glucose control.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要